Valerian B. Pinto

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression

Paul B. Keiser, Susan Biggs-Cicatelli, Elizabeth Morán et al. · Vaccine · 2011 · 136 citations

Vaccination, Group B Strain, Vaccine Development +10

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

Wendell D. Zollinger, M. A. Donets, Deborah H. Schmiel et al. · Vaccine · 2010 · 69 citations

Vaccination, Mucosal Vaccination, Cross-protection +9

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA

Paul B. Keiser, Barnett T. Gibbs, Trinka S. Coster et al. · Vaccine · 2010 · 62 citations

Vaccination, Deleted Lpxl2, Vaccine Development +10

Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B <i>Neisseria meningitidis</i> Vaccines Made from Lipid A Acylation Mutants

Mark B. Stoddard, Valerian B. Pinto, Paul B. Keiser et al. · Clinical and Vaccine Immunology · 2009 · 60 citations · Full text

Immunotoxicology, Microbial Pathogens, Laboratory Immunology +20

An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups

Valerian B. Pinto, Elizabeth Morán, Francisco Cruz et al. · Vaccine · 2011 · 26 citations

Vaccination, Vaccine Development, Bactericidal Activity +8